These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
154 related items for PubMed ID: 12551825
21. Distribution of von Willebrand factor levels in young women with and without bleeding symptoms: influence of ABO blood group and promoter haplotypes. Lethagen S, Hillarp A, Ekholm C, Mattson E, Halldén C, Friberg B. Thromb Haemost; 2008 Jun; 99(6):1013-8. PubMed ID: 18521502 [Abstract] [Full Text] [Related]
22. Laboratory diagnosis and monitoring of desmopressin treatment of von Willebrand's disease by flow cytometry. Giannini S, Mezzasoma AM, Leone M, Gresele P. Haematologica; 2007 Dec; 92(12):1647-54. PubMed ID: 18055988 [Abstract] [Full Text] [Related]
23. A first Taiwanese Chinese family of type 2B von Willebrand disease with R1306W mutation. Shen MC, Lin JS, Lin DS, Hsu SC, Lin B. Thromb Res; 2003 Dec; 112(5-6):291-5. PubMed ID: 15041272 [Abstract] [Full Text] [Related]
24. Endothelial cell activation and hypercoagulability in ocular Behçet's disease. Probst K, Fijnheer R, Rothova A. Am J Ophthalmol; 2004 May; 137(5):850-7. PubMed ID: 15126149 [Abstract] [Full Text] [Related]
25. Efficacy and safety of factor VIII/von Willebrand's factor concentrate (Haemate-P) in preventing bleeding during surgery or invasive procedures in patients with von Willebrand disease. Franchini M, Rossetti G, Tagliaferri A, Pattacini C, Pozzoli D, Lippi G, Manzato F, Bertuzzo D, Gandini G. Haematologica; 2003 Nov; 88(11):1279-83. PubMed ID: 14607757 [Abstract] [Full Text] [Related]
26. Intravenous DDAVP and factor VIII-von Willebrand factor concentrate for the treatment and prophylaxis of bleedings in patients With von Willebrand disease type 1, 2 and 3. Michiels JJ, van Vliet HH, Berneman Z, Gadisseur A, van der Planken M, Schroyens W, van der Velden A, Budde U. Clin Appl Thromb Hemost; 2007 Jan; 13(1):14-34. PubMed ID: 17164493 [Abstract] [Full Text] [Related]
27. Impaired dimerization of von Willebrand factor subunit due to mutation A2801D in the CK domain results in a recessive type 2A subtype IID von Willebrand disease. Hommais A, Stépanian A, Fressinaud E, Mazurier C, Pouymayou K, Meyer D, Girma JP, Ribba AS. Thromb Haemost; 2006 May; 95(5):776-81. PubMed ID: 16676067 [Abstract] [Full Text] [Related]
28. Reassessment of ABO blood group, sex, and age on laboratory parameters used to diagnose von Willebrand disorder: potential influence on the diagnosis vs the potential association with risk of thrombosis. Favaloro EJ, Soltani S, McDonald J, Grezchnik E, Easton L, Favaloro JW. Am J Clin Pathol; 2005 Dec; 124(6):910-7. PubMed ID: 16416741 [Abstract] [Full Text] [Related]
29. Impact of the Thr789Ala variant of the von Willebrand factor levels, on ristocetin co-factor and collagen binding capacity and its association with coronary heart disease in patients with diabetes mellitus type 2. Klemm T, Mehnert AK, Siegemund A, Wiesner TD, Gelbrich G, Blüher M, Paschke R. Exp Clin Endocrinol Diabetes; 2005 Dec; 113(10):568-72. PubMed ID: 16320153 [Abstract] [Full Text] [Related]
30. Diagnosis and follow-up of thrombotic thrombocytopenic purpura by means of von Willebrand factor collagen binding assay. Casonato A, Fabris F, Pontara E, Cattini MG, Zocca N, Gallinaro L, Girolami A, Pagnan A. Clin Appl Thromb Hemost; 2006 Jul; 12(3):296-304. PubMed ID: 16959682 [Abstract] [Full Text] [Related]
31. Platelet von Willebrand factor determination does not improve the diagnosis of patients with suspected Type 1 von Willebrand disease. Shihong I, Morris D, Konkle BA. Haemophilia; 2009 Jan; 15(1):131-4. PubMed ID: 18976254 [Abstract] [Full Text] [Related]
32. The hemostatic profiles of patients with Type O and non-O blood after acute normovolemic hemodilution with 6% hydroxyethyl starch (130/0.4). Kang JG, Ahn HJ, Kim GS, Hahm TS, Lee JJ, Gwak MS, Choi SJ. Anesth Analg; 2006 Dec; 103(6):1543-8. PubMed ID: 17122237 [Abstract] [Full Text] [Related]
33. Recessive von Willebrand disease type 2 Normandy: variable expression of mild hemophilia and VWD type 1. Michiels JJ, Gadisseur A, Vangenegten I, Schroyens W, Berneman Z. Acta Haematol; 2009 Dec; 121(2-3):119-27. PubMed ID: 19506358 [Abstract] [Full Text] [Related]
34. Relationship between ABO and Secretor genotype with plasma levels of factor VIII and von Willebrand factor in thrombosis patients and control individuals. Schleef M, Strobel E, Dick A, Frank J, Schramm W, Spannagl M. Br J Haematol; 2005 Jan; 128(1):100-7. PubMed ID: 15606555 [Abstract] [Full Text] [Related]
35. Non-surgical bleeding in patients with ventricular assist devices could be explained by acquired von Willebrand disease. Geisen U, Heilmann C, Beyersdorf F, Benk C, Berchtold-Herz M, Schlensak C, Budde U, Zieger B. Eur J Cardiothorac Surg; 2008 Apr; 33(4):679-84. PubMed ID: 18282712 [Abstract] [Full Text] [Related]
36. Guidelines for the evaluation of intravenous desmopressin and von Willebrand factor/factor VIII concentrate in the treatment and prophylaxis of bleedings in von Willebrand disease types 1, 2, and 3. Michiels JJ, Gadisseur A, van der Planken M, Schroyens W, van de Velden A, Berneman Z. Semin Thromb Hemost; 2006 Sep; 32(6):636-45. PubMed ID: 16977574 [Abstract] [Full Text] [Related]
39. Autosomal dominant von Willebrand disease type 2M. Hermans C, Batlle J. Acta Haematol; 2009 Sep; 121(2-3):139-44. PubMed ID: 19506360 [Abstract] [Full Text] [Related]
40. Managing patients with von Willebrand disease type 1, 2 and 3 with desmopressin and von Willebrand factor-factor VIII concentrate in surgical settings. Michiels JJ, van Vliet HH, Berneman Z, Schroyens W, Gadisseur A. Acta Haematol; 2009 Sep; 121(2-3):167-76. PubMed ID: 19506363 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]